We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Lab Tests Take Flight

By CLN Stat
Posted on 29 Jul 2019
Print article
(Photo courtesy of AACC)
(Photo courtesy of AACC)
A North Carolina medical facility has teamed up with national aviation, technology, and delivery service leaders to take part in the first medical drone delivery operation over a densely populated area of the United States, with a goal of improving patient care by speeding deliveries at a lower cost and expediting life-saving treatments.

Unmanned aviation drones deliver 10 times faster than ground transport, according to UPS, which has partnered with WakeMed Health & Hospitals in Raleigh, North Carolina, drone technology company Matternet, the Federal Aviation Administration (FAA), and North Carolina Department of Transportation (NCDOT) on this project. Since March, routine revenue flights have been taking place on the WakeMed campus under FAA and NCDOT oversight. Routine lab samples, which may include complete blood count and blood chemistry tests, liver function tests or cholesterol tests, travel by Matternet’s M2 Drone quadcopter from WakeMed Raleigh Medical Park’s outpatient clinic to WakeMed Raleigh Campus, its flagship hospital and site of the central pathology lab. Medical professionals load the sample encased in a secure container into the drone, and a remote pilot-in-command keeps track of each flight and troubleshoots any problems that arise.
Each drone is equipped with a parachute and other features to protect the samples in case of an emergency. However, the operators will either limit or pause drone flight in instances of high winds, ice, or rain.

Drone technology has the potential to transform health and healthcare delivery, Stuart Ginn, MD, WakeMed otolaryngologist and medical director for WakeMed Innovations, told CLN Stat. First-round test flights took place at WakeMed last summer, part of FAA’s 3-year Unmanned Aircraft System (UAS) Integration Pilot Program (IPP), which partners local governments with private sector companies to further investigate the commercial applications of drone technology.
“Our team has been working on UAS medical package delivery solutions for more than two years. We were thrilled when the FAA’s IPP was announced,” Ginn said. The application from WakeMed and its partners was one of 10 the FAA selected from a nationwide pool.

August 29, 2018, marked IPP’s first U.S. medical drone delivery test flight at WakeMed, in partnership with NCDOT’s Division of Aviation and Matternet. Following more than 100 test flights, UPS in March announced a new logistics service to deliver medical samples via unmanned drones. “This announcement, and the drone that took flight at WakeMed on March 26, was the next major milestone for unmanned aviation in the U.S., as it marked the first FAA-sanctioned use of a drone for routine revenue flights involving the transport of a product under a contractual delivery agreement,” explained Ginn.

Creating efficiencies in transporting routine blood and urine specimens is the initiative’s current focus. Courier vehicles will continue to transport items such as tissue samples from biopsies and pharmaceuticals although the partners are evaluating opportunities to move other items by UAS, such as pharmaceuticals, as the project expands. The ultimate goal is to build a network of UAS routes connecting all of the freestanding hospitals and healthplexes across the WakeMed system, according to Ginn. Next steps are to implement a UAS route connecting WakeMed’s Garner Healthplex to the WakeMed Raleigh Campus.

“The ability to work directly with regulators and technology leaders has allowed us to make tremendous progress,” Ginn said. “We’re proud to lead the way in developing this expertise for other healthcare systems who will use this technology in the future.”

Matternet may soon face some competition from other drone companies in the commercial space. Just recently, Wing, a subsidiary of Google parent Alphabet Inc. received FAA air carrier certification to deliver small commercial packages and has launched services in Virginia, with plans to expand. According to one news report, delivery items may include over-the-counter medications. The University of Maryland Medical Center (UMMC) in Baltimore also just announced that a drone flight had been used to deliver a kidney for transplant at UMMC.


Related Links:

AACC
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.